Our Mission
Effervescence Therapeutics is dedicated to revolutionizing the treatment of age-related and lifestyle diseases by developing innovative therapies that target efferocytosis and other key biological mechanisms.
Through cutting-edge research and strategic partnerships, we aim to unlock the potential of longevity science and rejuvenation technologies, transforming 21st-century healthcare to improve health span and quality of life for millions worldwide.
Our Vision
To lead a global revolution in healthcare by pioneering therapies that extend health span and rejuvenate lives. Effervescence Therapeutics envisions a future where age-related and lifestyle diseases are effectively managed, empowering people everywhere to live with vitality, resilience, and vivacity at every stage of life.
Team
Krzysztof B. Wicher, PhD
Founder/CEO
Researcher and scientific leader with more than 20 years of experience in various areas of molecular and cell biology, bioinformatics, cancer biology, biochemistry, biotechnology, and drug discovery, gained in academia and in industry. Previously, at Medimmune, Ossianix, Kymab, and recently Macomics.